Curaleaf Hldgs Stock Price, News & Analysis

Curaleaf Holdings, Inc. (OTCQX: CURLF, TSX: CURA) is described as a leading international provider of consumer products in cannabis. The company focuses on enhancing lives by cultivating, sharing and celebrating the power of the cannabis plant, and operates across both medical and adult-use markets. Its shares trade on the OTCQX market in the United States under the symbol CURLF and on the Toronto Stock Exchange under the symbol CURA.

According to the company’s own descriptions in multiple press releases, Curaleaf is a high-growth cannabis company known for quality, expertise and reliability. It operates under a portfolio of brands that includes Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company. Through these brands, Curaleaf offers consumer cannabis products and emphasizes service, product selection and accessibility for patients and customers.

Business focus and operations

Curaleaf states that it provides consumer cannabis products across medical and adult-use markets. In the United States, the company operates dispensaries and retail locations in a number of states. Recent company announcements highlight retail activity in Pennsylvania, where Curaleaf Millcreek in Erie serves patients, and in Florida, where Curaleaf Cape Canaveral and other locations operate as part of a broader statewide footprint. The company also references retail operations in states such as Arizona, Connecticut, Illinois, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York, Ohio, Pennsylvania and Utah in connection with its community initiatives.

Curaleaf’s retail locations offer cannabis products under its brands, including items such as premium flower, vapes and edibles, as described in its own press releases for specific dispensaries. The company also references product launches under its Anthem brand, such as Anthem Bold Infused Pre-Rolls in New York, New Jersey, Illinois and Arizona, and branded offerings like Select Briq and Select ACE in certain markets.

International presence

Curaleaf describes itself as having an international footprint through Curaleaf International, which it says is powered by a strong presence in all stages of the supply chain. The company states that its distribution network throughout Europe, Canada and Australasia brings together science and research with cultivation, extraction and production. It has highlighted international operations in markets such as the United Kingdom and Germany, including the launch of what it describes as the first medically certified liquid inhalation device, the QMID, in those countries.

The company has also reported international revenue and segment performance in its financial disclosures, distinguishing between domestic and international retail and wholesale revenue and management fee income.

Capital markets and financing

Curaleaf files as a foreign private issuer with the U.S. Securities and Exchange Commission on Form 6-K and indicates that it uses Form 40-F for certain filings. The company has referenced a registration statement on Form F-10 and provides unaudited condensed interim consolidated financial statements and management’s discussion and analysis through its SEC filings.

In its public communications, Curaleaf has announced a secured revolving credit facility with Needham Bank, which it describes as an upsized revolving credit facility expanding borrowing capacity from $40 million to $100 million and extending maturity up to five years. The company has indicated that this facility is intended to support working capital needs and pay down higher interest-bearing acquisition-related debt.

Corporate structure and proposed domestication

Curaleaf has reported that it is incorporated in British Columbia, Canada, and has filed multiple Form 6-K reports indicating a principal executive office in Vancouver, British Columbia. In a press release filed as an exhibit to a Form 6-K, the company announced its intention to seek shareholder approval for a proposed arrangement that would continue the company out of British Columbia and domesticate it in the State of Delaware in the United States. This proposed transaction, referred to as the Continuance, would involve the company continuing from the jurisdiction of British Columbia to Delaware.

Under the proposed plan of arrangement described by Curaleaf, each issued and outstanding subordinate voting share of the British Columbia-formed Curaleaf would be deemed to represent one share of subordinate voting common stock of the Delaware-continued Curaleaf. The same treatment is expected for multiple voting shares and exchangeable shares, and outstanding options and restricted share units would be adjusted under the company’s 2018 Stock and Incentive Plan to relate to Delaware subordinate voting shares on the same terms and conditions. The company has stated that the arrangement is not expected to cause any material change in its business or operations and that it expects its Delaware subordinate voting shares to continue to be listed on the TSX and quoted on OTCQX under the same symbols after completion.

Growth initiatives and retail footprint

Curaleaf regularly reports on its retail expansion and operational initiatives. In recent communications, the company has noted:

• The relocation of its Bradford, Pennsylvania dispensary to a new, expanded location in Erie, Pennsylvania, branded as Curaleaf Millcreek, while maintaining its total store count in Pennsylvania.
• The opening of a dispensary in Cape Canaveral, Florida, contributing to its Florida store count and broader nationwide footprint.
• Expansion of its domestic retail footprint in states such as Ohio and Florida, and the use of management services arrangements in Maine.
• Ongoing evaluation of acquisition opportunities, including a previously announced binding commitment to acquire The Cannabist Company’s Virginia assets, followed by a later announcement that this equity purchase agreement was terminated after a competing bid was accepted and Curaleaf determined that the competing valuation exceeded what it considered rational fair value for those assets. Curaleaf has indicated that it expects to receive a break fee in connection with that termination.

These disclosures illustrate how the company uses acquisitions, selective retail expansion and product launches to support its cannabis operations in various jurisdictions.

Financial reporting

Curaleaf reports its financial results in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and supplements these results with non-GAAP financial measures and ratios. In its own descriptions, the company defines measures such as adjusted gross profit, adjusted gross profit margin, adjusted net income (loss), adjusted EBITDA, adjusted EBITDA margin and free cash flow from operations. It explains that these measures are intended to provide additional insight into its financial strength and performance and to align with how management evaluates results, while noting that these measures do not have standardized definitions under U.S. GAAP and may not be comparable to similar measures used by other issuers.

Curaleaf has provided segment-level revenue information in its financial disclosures, distinguishing between domestic and international operations and between retail revenue, wholesale revenue and management fee income. The company also reports on cash balances, outstanding debt, capital expenditures and other balance sheet items in its filings and press releases.

Community and social initiatives

Curaleaf highlights community engagement as part of its activities. One example is its recurring Feed the Block fundraiser, which the company describes as a nationwide initiative to help combat food insecurity in communities where it operates. According to Curaleaf, Feed the Block has raised funds and collected food donations for local food banks and nonprofit partners through round-up campaigns at participating dispensaries and volunteer activities by team members. The company states that this initiative has provided resources to local organizations and meals to families across multiple U.S. states.

Curaleaf has also mentioned partnerships with organizations such as the Baldwin Fund to raise funds for breast cancer research, indicating that it pursues philanthropic and community-based efforts alongside its core cannabis business.

Regulatory filings and status

Curaleaf files periodic reports with the U.S. Securities and Exchange Commission on Form 6-K as a foreign issuer. These filings typically include press releases, financial statements, management’s discussion and analysis, and certifications by senior officers. The company has also referenced a registration statement on Form F-10 and uses Form 40-F for certain filings. The available filings do not indicate a delisting or deregistration event, and the company continues to reference its listings on the TSX and OTCQX in its press releases.

FAQs about Curaleaf Holdings, Inc.

• What does Curaleaf Holdings, Inc. do?
  Curaleaf Holdings, Inc. describes itself as a leading international provider of consumer products in cannabis. The company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company, offer cannabis products and related services across medical and adult-use markets.
• Where are Curaleaf’s shares traded?
  Curaleaf states that its shares are listed on the Toronto Stock Exchange under the symbol CURA and trade on the OTCQX market in the United States under the symbol CURLF.
• What brands are part of the Curaleaf portfolio?
  In its press releases, Curaleaf identifies its brands as Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company. These brands are used for various cannabis product lines and offerings in different markets.
• How does Curaleaf describe its international operations?
  Curaleaf reports that Curaleaf International has a strong presence in all stages of the supply chain and that its distribution network throughout Europe, Canada and Australasia combines science and research with cultivation, extraction and production. It has referenced activities in the United Kingdom and Germany, including the launch of the QMID device.
• What is Curaleaf’s proposed domestication to Delaware?
  Curaleaf has announced a proposed arrangement under which it would continue from the jurisdiction of British Columbia, Canada to the State of Delaware in the United States. Under this plan, existing subordinate voting shares, multiple voting shares and exchangeable shares of the British Columbia company would be deemed to represent corresponding shares of the Delaware-continued company, and outstanding options and restricted share units would be adjusted under its equity incentive plan. The company has stated that this change is not expected to cause any material change in its business or operations.
• How does Curaleaf report its financial results?
  Curaleaf reports financial results under U.S. GAAP and also uses non-GAAP measures such as adjusted gross profit, adjusted EBITDA and free cash flow from operations. It provides definitions and reconciliations for these measures in its financial disclosures and explains that they are used to evaluate performance and financial strength.
• What types of retail activities has Curaleaf highlighted?
  Curaleaf has reported on the opening and relocation of dispensaries in states such as Pennsylvania and Florida, including Curaleaf Millcreek in Erie and Curaleaf Cape Canaveral. It also notes expansion of its retail footprint in states like Ohio and Florida, and the use of management services arrangements in Maine.
• What community initiatives does Curaleaf mention?
  Curaleaf describes its Feed the Block fundraiser as a nationwide initiative to address food insecurity through donations and volunteer activities at its dispensaries. It has also mentioned partnerships with organizations such as the Baldwin Fund to support breast cancer research.
• How is Curaleaf regulated as a public company?
  Curaleaf files reports with the U.S. Securities and Exchange Commission on Form 6-K and references a registration statement on Form F-10 and filings on Form 40-F. It also files with Canadian securities regulators and notes that certain documents are available on SEDAR+.
• Has Curaleaf announced any significant acquisition-related decisions?
  Curaleaf announced that it had entered into a binding commitment to acquire The Cannabist Company’s Virginia assets, including a cultivation facility and retail dispensaries, and later reported that this equity purchase agreement was terminated after a competing bid. The company indicated that it expects to receive a break fee in connection with the termination and stated that it will remain disciplined in its acquisition strategy.